Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations

Human Immunology

Volumn 71, Issue 6, 2010, Pages 610-620

  Antoun, Ayman ^a   Jobson, Shirley ^b   Cook, Mark ^c   O'Callaghan, Chris A ^d   Moss, Paul ^a   Briggs, David C ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Innate immunity; NKG2D ligands; Polymorphism; Population genetics; RAET1; ULBP

Indexed keywords

BINDING PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; RETINOIC ACID EARLY TRANSCRIPT 1 PROTEIN; RETINOIC ACID EARLY TRANSCRIPT 1E PROTEIN; RETINOIC ACID EARLY TRANSCRIPT 1G PROTEIN; RETINOIC ACID EARLY TRANSCRIPT 1L PROTEIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; RAET1E PROTEIN, HUMAN; RAET1G PROTEIN, HUMAN; RAET1L PROTEIN, HUMAN; SIGNAL PEPTIDE; ULBP1 PROTEIN, HUMAN; ULBP2 PROTEIN, HUMAN;

AFRICAN CARIBBEAN; ARTICLE; ASIAN; CAUCASIAN; CHROMOSOME 6; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; GENE CLUSTER; GENE FREQUENCY; GENE LINKAGE GROUP; GENETIC ANALYSIS; GENETIC CONSERVATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM; ANCESTRY GROUP; COMPUTER SIMULATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE;

CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 6; COMPUTER SIMULATION; CONTINENTAL POPULATION GROUPS; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MEMBRANE PROTEINS; MULTIGENE FAMILY; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POLYMORPHISM, SINGLE NUCLEOTIDE; GPI-LINKED PROTEINS;

EID: 77952887985     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.02.018     Document Type: Article

References (53)

1. Norman P.J., Parham P. Complex interactions: The immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors. Semin Hematol 2005, 42:65-75.
2. Single R.M., Martin M.P., Gao X., Meyer D., Yeager M., Kidd J.R., et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 2007, 39:1114-1119.
3. Cerwenka A., Lanier L.L. NKG2D ligands: Unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens 2003, 61:335-343.
4. Lanier L.L. Up on the tightrope: Natural killer cell activation and inhibition. Nat Immunol 2008, 9:495-502.
5. Sutherland C.L., Chalupny N.J., Schooley K., VandenBos T., Kubin M., Cosman D. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol 2002, 168:671-679.
6. Vivier E., Tomasello E., Paul P. Lymphocyte activation via NKG2D: Towards a new paradigm in immune recognition?. Curr Opin Immunol 2002, 14:306-311.
7. Gonzalez S., Lopez-Soto A., Suarez-Alvarez B., Lopez-Vazquez A., Lopez-Larrea C. NKG2D ligands: Key targets of the immune response. Trends Immunol 2008, 29:397-403.
8. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
9. Strong R.K. Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer. Mol Immunol 2002, 38:1029-1037.
10. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001, 14:123-133.
11. Radaev S., Rostro B., Brooks A.G., Colonna M., Sun P.D. Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 2001, 15:1039-1049.
12. Groh V., Rhinehart R., Secrist H., Bauer S., Grabstein K.H., Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A 1999, 96:6879-6884.
13. Radosavljevic M., Cuillerier B., Wilson M.J., Clement O., Wicker S., Gilfillan S., et al. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 2002, 79:114-123.
14. Eleme K., Taner S.B., Onfelt B., Collinson L.M., McCann F.E., Chalupny N.J., et al. Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D. J Exp Med 2004, 199:1005-1010.
15. Rolle A., Mousavi-Jazi M., Eriksson M., Odeberg J., Soderberg-Naucler C., Cosman D., et al. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: Up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. J Immunol 2003, 171:902-908.
16. Gasser S., Orsulic S., Brown E.J., Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436:1186-1190.
17. Zwirner N.W., Fuertes M.B., Girart M.V., Domaica C.I., Rossi L.E. Cytokine-driven regulation of NK cell functions in tumor immunity: Role of the MICA-NKG2D system. Cytokine Growth Factor Rev 2007, 18:159-170.
18. Salih H.R., Rammensee H.G., Steinle A. Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 2002, 169:4098-4102.
19. Steinle A., Li P., Morris D.L., Groh V., Lanier L.L., Strong R.K., et al. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001, 53:279-287.
20. Li P., Morris D.L., Willcox B.E., Steinle A., Spies T., Strong R.K. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2001, 2:443-451.
21. Radaev S., Kattah M., Zou Z., Colonna M., Sun P.D. Making sense of the diverse ligand recognition by NKG2D. J Immunol 2002, 169:6279-6285.
22. Li P., McDermott G., Strong R.K. Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. Immunity 2002, 16:77-86.
23. Salih H.R., Holdenrieder S., Steinle A. Soluble NKG2D ligands: Prevalence, release, and functional impact. Front Biosci 2008, 13:3448-3456.
24. Dunn C., Chalupny N.J., Sutherland C.L., Dosch S., Sivakumar P.V., Johnson D.C., et al. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med 2003, 197:1427-1439.
25. Groh V., Rhinehart R., Randolph-Habecker J., Topp M.S., Riddell S.R., Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001, 2:255-260.
26. Eagle R.A., Traherne J.A., Ashiru O., Wills M.R., Trowsdale J. Regulation of NKG2D ligand gene expression. Hum Immunol 2006, 67:159-169.
27. Hamerman J.A., Ogasawara K., Lanier L.L. NK cells in innate immunity. Curr Opin Immunol 2005, 17:29-35.
28. Bahram S. MIC genes: From genetics to biology. Adv Immunol 2000, 76:1-60.
29. Hubbard T.J., Aken B.L., Beal K., Ballester B., Caccamo M., Chen Y., et al. Ensembl 2007. Nucleic Acids Res 2007, 35:D610-D617.
30. Cook M.A., Moss P.A., Briggs D.C. The distribution of 13 killer-cell immunoglobulin-like receptor loci in UK blood donors from three ethnic groups. Eur J Immunogenet 2003, 30:213-221.
31. Antoun A., Jobson S., Cook M., Moss P., Briggs D. Ethnic variability in human leukocyte antigen-E haplotypes. Tissue Antigens 2009, 73:39-45.
32. Excoffier L., Laval G., Schneider S. Arlequin (Version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 1:47-50.
33. Reich D.E., Cargill M., Bolk S., Ireland J., Sabeti P.C., Richter D.J., et al. Linkage disequilibrium in the human genome. Nature 2001, 411:199-204.
34. Ahmad T., Neville M., Marshall S.E., Armuzzi A., Mulcahy-Hawes K., Crawshaw J., et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet 2003, 12:647-656.
35. Schwede T., Kopp J., Guex N., Peitsch M.C. An automated protein homology-modeling server. Nucleic Acids Res 2003, 31:3381-3385. SWISS-MODEL.
36. Holmes M.A., Li P., Petersdorf E.W., Strong R.K. Structural studies of allelic diversity of the MHC class I homolog MIC-B, a stress-inducible ligand for the activating immunoreceptor NKG2D. J Immunol 2002, 169:1395-1400.
37. Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997, 53:240-255.
38. Emsley P., Cowtan K. Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004, 60:2126-2132.
39. DeLano WL. The PyMOL User's Manual. Scientific, Palo Alto, CA, 2002.
40. Romphruk A.V., Romphruk A., Naruse T.K., Raroengjai S., Puapairoj C., Inoko H., Leelayuwat C. Polymorphisms of NKG2D ligands: Diverse RAET1/ULBP genes in northeastern Thais. Immunogenetics 2009, 61:611-617.
41. Rodriguez-Rodero S., Gonzalez S., Rodrigo L., Fernandez-Morera J.L., Martinez-Borra J., Lopez-Vazquez A., et al. Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur J Immunol 2007, 37:1938-1953.
42. Borchers M.T., Harris N.L., Wesselkamper S.C., Vitucci M., Cosman D. NKG2D ligands are expressed on stressed human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006, 291:L222-L231.
43. Salisbury B.A., Pungliya M., Choi J.Y., Jiang R., Sun X.J., Stephens J.C. SNP and haplotype variation in the human genome. Mutat Res 2003, 526:53-61.
44. Hughes A.L., Welch R., Puri V., Matthews C., Haque K., Chanock S.J., et al. Genome-wide SNP typing reveals signatures of population history. Genomics 2008, 92:1-8.
45. Miller L.H., Mason S.J., Clyde D.F., McGinniss M.H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976, 295:302-304.
46. Gilles H.M., Fletcher K.A., Hendrickse R.G., Lindner R., Reddy S., Allan N. Glucose-6-phosphate-dehydrogenase deficiency, sickling, and malaria in African children in south western Nigeria. Lancet 1967, 1:138-140.
47. Fortin A., Stevenson M.M., Gros P. Susceptibility to malaria as a complex trait: Big pressure from a tiny creature. Hum Mol Genet 2002, 11:2469-2478.
48. Hansen D.S., D'Ombrain M.C., Schofield L. The role of leukocytes bearing natural killer complex receptors and killer immunoglobulin-like receptors in the immunology of malaria. Curr Opin Immunol 2007, 19:416-423.
49. Roetynck S., Baratin M., Johansson S., Lemmers C., Vivier E., Ugolini S. Natural killer cells and malaria. Immunol Rev 2006, 214:251-263.
50. Prugnolle F., Manica A., Charpentier M., Guégan J.F., Guernier V., Balloux F. Pathogen-driven selection and worldwide HLA class I diversity. Curr Biol 2005, 15:1022-1027.
51. Caillat-Zucman S. How NKG2D ligands trigger autoimmunity?. Hum Immunol 2006, 67:204-207.
52. Groh V., Bruhl A., El-Gabalawy H., Nelson J.L., Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 2003, 100:9452-9457.
53. Yamada R., Yamamoto K. Mechanisms of disease: Genetics of rheumatoid arthritis-ethnic differences in disease-associated genes. Nat Clin Pract Rheumatol 2007, 3:644-650.